# US 2017/0253938 A1 · Dividing of reporter proteins by dna sequences and its application in site specific recombination

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0253938 A1
- Document ID: US20170253938A1
- Status: Published application
- Kind: A1
- Application number: 15/445,799
- Filed: 2017-02-28
- Published: 2017-09-07
- Earliest claimed: 2016-02-29
- Assignees: Ingenious Targeting Laboratories
- Inventors: Wei Weng
- Web page: https://patentgrep.com/patent/US20170253938A1

## CPC

- C12Q 1/6897: involving reporter genes operably linked to promoters
- A01K 67/0276: Knock-out vertebrates
- C12N 15/63: Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N 15/8509: {for producing genetically modified animals, e.g. transgenic}
- C22C 38/00: Ferrous alloys, e.g. steel alloys (cast-iron alloys C22C37/00)
- E04C 5/02: of low bending resistance, i.e. of essentially one-dimensional [1D] or two-dimensional [2D] extent
- A01K 2217/075: inducing loss of function, i.e. knock out
- A01K 2227/105: Murine
- B21J 5/08: Upsetting
- C12N 2800/30: Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
- C12N 2830/42: being an intron or intervening sequence for splicing and/or stability of RNA
- E04C 5/03: with indentations, projections, ribs, or the like, for augmenting the adherence to the concrete
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C22C: ALLOYS (treatment of alloys C21D, C22F)
- E04C: STRUCTURAL ELEMENTS; BUILDING MATERIALS (for bridges E01D; specially designed for insulation or other protection E04B; elements used as building aids E04G; for mining E21; for tunnels E21D; structural elements with broader range of application than for building engineering F16, particularly F16S)
- B21J: FORGING; HAMMERING; PRESSING METAL; RIVETING; FORGE FURNACES (rolling of metal B21B; making particular products by forging or pressing B21K; cladding or plating B23K; finishing surfaces by hammering B23P9/04; compacting surfaces by blasting with particulate material B24C1/10; general features of presses, presses for consolidating scrap B30B; furnaces in general F27)

## Abstract

Methods and constructs for inserting an intron into a reporter protein coding sequence in a eukaryotic cell and their application of monitoring and reporting genomic modifications are provided. Various related compositions, cells and kits are also provided.

## Claims

### Claim 1

A recombinant nucleic acid construct comprising in order from upstream to downstream:
a promoter sequence;
a nucleic acid sequence encoding a first portion of a reporter protein including an N-terminus, wherein a protein product of the reporter protein is insufficient to provide reporter expression;
a splice donor site;
a heterologous nucleic acid sequence;
a splice acceptor site;
a nucleic acid sequence encoding a second portion of a reporter protein including a C-terminus; and
a poly(A) signal sequence.

### Claim 2 (depends on 1)

A method of introducing conditional and divided polynucleotide sequences coding for a reporter protein into a mouse embryonic stem (ES) cell, comprising:
(a) constructing a DNA targeting vector comprising, in order,
a 5′ homology arm;
construct according to claim 1, wherein the heterologous sequence comprises a target sequence flanked by two recombination sites; and
a 3′ homology arm,
wherein the DNA targeting vector further comprises an antibiotic selectable marker gene inserted between the 5′ homology arm and 3′ homology arm;
(b) introducing the DNA targeting vector of (a) into an ES cell;
(c) selecting the ES cell of (b) for a targeted clone.

### Claim 3 (depends on 2)

A method of reporting gene deletion comprising,
(a) constructing a DNA targeting vector according to claim 2;
(b) generating targeted germline mouse;
(c) mating the targeted mouse with a recombinase expressing mouse;
(d) activing a reporter protein by removing the target sequence by recombination between said recombination sites.

### Claim 4 (depends on 1)

The nucleic acid construct of claim 1, wherein the promoter is a nucleic acid sequence capable of driving gene expression of downstream sequences in eukaryotic cells.

### Claim 5 (depends on 4)

The nucleic acid construct of claim 4, wherein the promoter is a polymerase II promoter.

### Claim 6 (depends on 4)

The promoter of claim 4, wherein promoter is selected from the group consists of ubiquitous promoter, cell specific promoter, inducible promoter, and constitutive promoter in eukaryotic cells

### Claim 7 (depends on 6)

The promoter of claim 6, wherein promoter is selected from the CAG (SEQ ID NO: 1), CAGGS, CMV, hCMV, EF1, PGK, FABP, Lck, CamKII, CD19, Keratin, Albumin, aP2, Insulin, MCK, MyHC, WAP, Col2A, Mx, tet, and Trex promoter.

### Claim 8 (depends on 1)

The nucleic acid construct of claim 1, wherein the reporter protein comprises a fluorescent protein, wherein said fluorescent protein is a protein capable of absorption of a higher energy photon and emission of a lower energy photon in eukaryotic cells.

### Claim 9 (depends on 8)

The nucleic acid construct of claim 8, wherein fluorescent protein is selected from the group consisting of blue/UV fluorescent proteins, cyan fluorescent proteins, green fluorescent proteins, yellow fluorescent proteins, orange fluorescent proteins, red fluorescent proteins, far-red fluorescent proteins, Near-IR fluorescent proteins, Long strokes shift fluorescent proteins, Photoactivable fluorescent proteins, Photoconvertible fluorescent proteins, and Photoswitchable fluorescent proteins.

### Claim 10 (depends on 9)

The nucleic acid construct of claim 9, wherein fluorescent protein is selected from GFP, EGFP (SEQ ID NO: 2), and DsRed (SEQ ID NO: 3).

### Claim 11 (depends on 1)

The nucleic acid construct of claim 1, wherein the splice donor site is a functional DNA sequence at beginning of an intron which can be spliced by splicesome.

### Claim 12 (depends on 11)

The nucleic acid construct of claim 11, wherein the first nucleotide of a 5′ end of the intron is a G.

### Claim 13 (depends on 1)

The nucleic acid construct of claim 1, wherein the splice acceptor site is a functional DNA sequence at the end which can be spliced by splicesome.

### Claim 14 (depends on 13)

The nucleic acid construct of claim 13, wherein the last nucleotide of a 3′ end of the intron is a G.

### Claim 15 (depends on 2)

The nucleic acid construct of claim 2, wherein both of the recombination sites are identical.

### Claim 16 (depends on 2)

The nucleic acid construct of claim 2, wherein both of the recombination sites are not identical.

### Claim 17 (depends on 2)

The nucleic acid construct of claim 2, wherein one of the recombination sites is a mutant recombination site.

### Claim 18 (depends on 2)

The nucleic acid construct of claim 2, wherein at least one recombination site is a wildtype recombination site consists of loxp (SEQ ID NO: 4), frt (SEQ ID NO: 5), rox (SEQ ID NO: 6), Vlox, Slox, attR, attL, attP, attB, or IR/DR sequences.

### Claim 19 (depends on 17)

The nucleic acid construct of claim 17, wherein one of the recombination site is selected from the group consisting of lox511, lox5171, lox2272, M2, M7, M11, lox71, lox66, loxN, loxp 5171, F3, F5, F7, FL-IL10A, Vlox2272, Slox2272, VloxM1, SloxM2, VloxM2, SloxM2, Vlox43R, Vlox43L, Slox1R, or Slox1L.

### Claim 20 (depends on 3)

The method of claim 3, wherein the recombinase is an enzyme capable of deleting or inversing sequence between two recombination sites.

### Claim 21 (depends on 3)

The method of claim 3, wherein the recombinase is an enzyme capable of deleting or inversing sequence between two of recombination sites.

### Claim 22 (depends on 20)

The method of claim 20, wherein the recombinase is Cre, Flp, Dre, Vcre, Scre, Nigri, Panto, PhiC31, or Sleepingbeauty transposon.

### Claim 23 (depends on 2)

The method of claim 2, wherein the heterologous sequence further comprises an exon trapping sequence.

### Claim 24 (depends on 23)

The method of claim 23, wherein the exon trapping sequence is EN2 exon trapping sequence (SEQ ID NO: 7).

### Claim 25 (depends on 2)

The method of claim 2, the heterologous sequence wherein the 3′ homology arm further comprises a nucleotide sequence coding for a second fluorescent protein.

### Claim 26 (depends on 2)

The method of claim 2, wherein the heterologous sequence further comprises a nucleotide sequence coding for a second reporter protein.

### Claim 27 (depends on 26)

The method of claim 26, wherein the second reporter protein is a second fluorescent protein.

### Claim 28 (depends on 26)

The nucleic acid construct of claim 26, wherein the second reporter protein is beta-galactosidase, luciferase, or chloramphenicol acetyltransferase.

### Claim 29 (depends on 1)

The nucleic acid construct of claim 1, wherein the reporter protein is selected from the group consisting of beta-galactosidase, luciferase, and chloramphenicol acetyltransferase.

### Claim 29 (depends on 8)

The nucleic acid construct of claim 8, wherein fluorescent protein is selected from the group consisting of blue/UV fluorescent proteins, cyan fluorescent proteins, green fluorescent proteins, yellow fluorescent proteins, orange fluorescent proteins, red fluorescent proteins, far-red fluorescent proteins, Near-IR fluorescent proteins, Long strokes shift fluorescent proteins, Photoactivable fluorescent proteins, Photoconvertible fluorescent proteins, and Photoswitchable fluorescent pro
